Richard-Carpentier, G. (2023). Venetoclax-based lower-intensity regimens for acute myeloid leukemia: Clinical pearls for a new standard of care. Canadian Hematology Today, 2(1), 28–33. https://doi.org/10.58931/cht.2023.2125